Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Dyad granted U.S. patent for oligonucleotides

Aug. 23, 1996

Protein Polymer Technologies and Ethicon sign R&D agreement

Aug. 23, 1996

Microsponge retinol system to be codeveloped by APS and Avon

Aug. 16, 1996

Phytopharm files for U.K. marketing approval of Zemaphyte

Aug. 16, 1996

Psoriasin role in psoriasis pathology under scrutiny

Aug. 16, 1996

FK-506: A safe and effective atopic dermatitis treatment

Aug. 9, 1996

Celley issued patent for physiologic lipid mixture from Australian authorities

Aug. 9, 1996

Johnson & Johnson files patent infringement complaint against Penederm

Aug. 9, 1996

Kaken submits NDA for Fiblast in Japan

Aug. 9, 1996

Isotretinoin effective against acne

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...